This is unpublished
Mazyar
Shadman
M.D.
M.P.H.
M.D.
M.P.H.

(206) 667-5467
Fred Hutchinson Cancer Center
1100 Fairview Ave. N, D5-390
Seattle, WA 98109
he, him, his
Physician & Research Faculty
Pinned
Academic
Associate Professor, Clinical Research Division, Fred Hutchinson Cancer Center
Associate Professor, Division of Medical Oncology, University of Washington
Sites of Practice
Fred Hutchinson Cancer Center - South Lake Union
Photo: Fred Hutch
Education, Training, Board Certifications
- M.D., Tehran University of Medical Sciences, Iran
- M.P.H., University of Washington
- Residency, Cleveland Clinic
- Fellowship in Hematology-Oncology, UW
- Medical Oncology, American Board of Internal Medicine
- Hematology, American Board of Internal Medicine
- Internal Medicine, American Board of Internal Medicine
Clinical Expertise
- Chronic lymphocytic leukemia
- Lymphoma and lymphoid malignancies
- Immunotherapy (CAR T-cell therapy)
- Hematopoietic stem cell transplantation
Affiliations
- Fred Hutchinson Cancer Center - Faculty & Lab
- University of Washington
- Fred Hutchinson Cancer Center - Provider
Publications
Research and/or clinical interests
Dr. Mazyar Shadman is a blood cancer specialist who focuses on lymphoid malignancies. He is involved in clinical research using novel therapeutic agents for lymphoma and chronic lymphocytic leukemia (CLL), immunotherapy (specifically CAR T-cell therapy) for lymphoid neoplasms, and blood stem cell transplantation for hematologic malignancies. His goal is to identify the best treatment sequence or combination for patients with high-risk lymphoma and CLL.
Current research topics include:
- Therapeutic clinical trials in lymphoid malignancies with a focus on CLL/SLL
- CAR T-cell therapy for lymphoma/CLL
- Clinical outcome research in lymphoid malignancies
- Epidemiology of hematologic malignancies